{"schema_version":"1","generated_at":"2026-10-28T22:03:49.284Z","data_as_of":null,"url":"https://www.findmykol.com/kol/elina-jerschow","json_url":"https://www.findmykol.com/kol/elina-jerschow/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"elina-jerschow","name":"Elina Jerschow","credential":"MD","specialty":"Allergy & Immunology","specialty_raw":"Allergy & Immunology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"Mayo Clinic","institution_url":"https://www.findmykol.com/institution/mayo-clinic","city":"Rochester","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1922197235","orcid":"0000-0002-9066-2483","openalex":"A5083840207"},"summary":"Elina Jerschow is a Rheumatology/Immunology physician affiliated with Mayo Clinic. OpenAlex indexes 136 publications with 2,601 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":136,"cited_by_count":2601,"h_index":22,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03158831","title":"Drug Challenges Without Prior Skin Testing","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Montefiore Medical Center","source_url":"https://clinicaltrials.gov/study/NCT03158831","trial_url":"https://www.findmykol.com/trial/NCT03158831"},{"nct":"NCT01320072","title":"Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease","status":"TERMINATED","role":"Overall official","sponsor":"Montefiore Medical Center","source_url":"https://clinicaltrials.gov/study/NCT01320072","trial_url":"https://www.findmykol.com/trial/NCT01320072"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"Regeneron Pharmaceuticals, Inc.","program_year":2025,"amount_usd":5067.75,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922197235"},{"payer":"GlaxoSmithKline, LLC.","program_year":2025,"amount_usd":2861.87,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922197235"},{"payer":"Regeneron Pharmaceuticals, Inc.","program_year":2024,"amount_usd":6990,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922197235"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1922197235","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Respiratory","share_pct":100,"classes_total":4,"classes":[{"class":"Histamine-1 Receptor Antagonist","setting":"prescribed","share_pct":43.3,"drugs":[{"name":"Azelastine Hcl","share_pct":100}],"max_beneficiaries":null},{"class":"Anti-IgE","setting":"prescribed","share_pct":20.9,"drugs":[{"name":"Xolair","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":2021,"last":2025},"rows_total":3,"shown":3,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21AI171306","title":"Staphylococcus aureus and eicosanoid dysregulation as drivers of inflammation in aspirin-exacerbated respiratory disease","fiscal_year":2025,"amount_usd":"201587","organization":"MAYO CLINIC ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R21AI171306"},{"project":"R21AI171306","title":"Staphylococcus aureus and eicosanoid dysregulation as drivers of inflammation in aspirin-exacerbated respiratory disease","fiscal_year":2024,"amount_usd":"241937","organization":"MAYO CLINIC ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R21AI171306"},{"project":"R21AI146804","title":"Th2A cells mediate outcomes of aspirin exacerbated respiratory disease","fiscal_year":2021,"amount_usd":"46730","organization":"MAYO CLINIC ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R21AI146804"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Recent progress in Stevens–Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment","year":2024,"journal":"British Journal of Dermatology","source_url":"https://doi.org/10.1093/bjd/ljae321","status":"verified"},{"title":"Updates on the Natural History and Clinical Characteristics of NSAID-ERD","year":2024,"journal":"The Journal of Allergy and Clinical Immunology In Practice","source_url":"https://doi.org/10.1016/j.jaip.2024.07.013","status":"verified"},{"title":"Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence","year":2023,"journal":"The Journal of Allergy and Clinical Immunology In Practice","source_url":"https://doi.org/10.1016/j.jaip.2023.07.035","status":"verified"},{"title":"Elaborate biologic approval process delays care of patients with moderate-to-severe asthma","year":2023,"journal":"Journal of Allergy and Clinical Immunology Global","source_url":"https://doi.org/10.1016/j.jacig.2022.10.007","status":"verified"},{"title":"Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma","year":2022,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2118813","status":"verified"}],"source":"works"},"contact":{"address_1":"200 1ST ST SW","city":"Rochester","state":"MN","zip":"559050001","phone":"507-284-2511","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1922197235","source":"identity"},"similar":[{"name":"S Rajkumar","slug":"s-rajkumar","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/s-rajkumar","json_url":"https://www.findmykol.com/kol/s-rajkumar/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":8,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-06-23","provider_certified":"2022-06-23","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}